The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
about
Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit.Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitisCloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study.Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.Identification of antigenic components of Staphylococcus epidermidis expressed during human infection.Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options.Vancomycin resistance in staphylococci.SdrG, a fibrinogen-binding bacterial adhesin of the microbial surface components recognizing adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the thrombin cleavage site in the Bbeta chain.Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.Ability of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand.In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococciDaptomycin dose-effect relationship against resistant gram-positive organismsMolecular characterization of methicillin-resistant Staphylococcus epidermidis clones: evidence of geographic dissemination.Antimicrobial-resistant, Gram-positive bacteria among patients undergoing chronic hemodialysis.Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.Prophylactic use of vancomycin in adult cardiology and cardiac surgery.Heteroresistant Vancomycin Intermediate Coagulase Negative Staphylococcus in the NICU: A Systematic Review.Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneriForeign body infections due to Staphylococcus epidermidis.Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care Unit.Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996-1999Artificial opsonin enhances bacterial phagocytosis, oxidative burst and chemokine production by human neutrophils.Linezolid Treatment for Osteomyelitis due to Staphylococcus Epidermidis with Reduced Vancomycin Susceptibility.Vancomycin MIC for methicillin-resistant coagulase-negative Staphylococcus isolates: evaluation of the broth microdilution and Etest methods.Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.Detection of methicillin-resistance gene in Staphylococcus epidermidis strains isolated from patients in Al-Zahra Hospital using polymerase chain reaction and minimum inhibitory concentration methodsDaptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis.Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, GreeceVancomycin and daptomycin pharmacodynamics differ against a site-directed Staphylococcus epidermidis mutant displaying the small-colony-variant phenotype.INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection.Antimicrobial proficiency testing of National Nosocomial Infections Surveillance System hospital laboratories.Vancomycin-intermediate Staphylococcus epidermidis: curio or omen?
P2860
Q24532922-C6965988-9F34-4E1B-93B8-E72943438FF1Q24646621-4152649A-0579-4A4E-982D-679B25ADCFC9Q25256319-E087F17F-C474-4D81-9DD3-DD5D0EF9286CQ30433993-777635DC-ED42-4678-8263-8AFDF01BF05AQ33251441-29E9B8B7-2E92-4019-9278-3773A43777BEQ33460707-931985D9-D2FE-4DB8-9742-91DE25B034C2Q33906522-373A6BB8-344C-45FB-9422-4473779B9A50Q33948050-9022E3E7-7B4C-428C-B017-5BEEBE65B755Q33966785-644A8376-FEA6-4B80-936B-A63BEC43E286Q33970955-0DE54F1C-511B-4172-A4D5-5D153FB6E5DAQ33971217-67D1DB9F-859A-4E0F-B24E-FC72EFD782F6Q34737427-4934DF32-41AE-43A2-9D43-A47D397D349EQ34936759-65B91E5C-3242-4D37-A129-9937D5EC533EQ34944920-04AEACBC-33A5-45F7-983C-2D426AE4C496Q34985828-F2C2B836-38E9-410F-AECF-9A3FB1FDB224Q35009236-306A4822-4FE8-4DBF-92DF-6B04531D2673Q35750208-0F544312-C856-44E3-BF99-AD3B941E65BDQ36157736-194A3B90-FBAD-4996-B219-03B07ED93109Q36328966-877AC556-4A2F-4B2C-B128-972BCA7640CAQ36891450-AA2245CD-0492-46BF-8211-AB7CFD4B8726Q37249440-39B6A717-8BC7-4BAD-9D7E-298788D4C21FQ37287797-AFBD0CFB-2BAF-4F36-A63C-019537A51A72Q37320018-58F01B66-C54D-42E7-819E-90EF1DA55CAAQ40072409-7D36B9ED-949A-4FD8-B3A9-555F924BA7F4Q40401780-E1D349E2-A171-43E1-9E54-69768C6F535CQ41428954-66546961-8F08-4B8A-A322-94F302C1137EQ41711192-5C81800B-2EF1-4F17-81CC-A73790852F6AQ41839959-3937A124-4409-496D-B42C-5C8DD8A31303Q41874503-622B6595-9CA5-4144-A685-E1A0A2D1E7F0Q42037140-2B5DD29A-FEED-47FE-881D-D3DB3403710FQ42535962-D0744FCC-07C4-4D8F-89CB-A40B219A9485Q42545845-C537EA27-E28E-42EC-84B3-F1D98EF9EA22Q44090632-C3CFF61A-2DF2-4C27-9943-49871CC5C2FEQ44464884-ED84D04C-2237-462A-9922-47925F7C2649Q54101396-F038ABF0-0110-4580-AFD5-824CC1F83D74
P2860
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
@en
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
@nl
type
label
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
@en
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
@nl
prefLabel
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
@en
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
@nl
P2093
P2860
P356
P1476
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
@en
P2093
D O Garrett
E Jochimsen
F C Tenover
J Johnston
P2860
P304
P356
10.1086/501605
P577
1999-03-01T00:00:00Z